pharmaceutical investing Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
pharmaceutical investing EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
Video - CEO Clips: Blue Jay Gold: Why Are District-Scale Gold Projects Attracting Investor Attention?